ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Grassley Pledges More Congressional Oversight of CME.

March 14, 2008

Byrd Seeks Federal Tar-Nicotine Limit

October 22, 1976

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

April 29, 1994

Advisors Approve CCOP, EDRN, Pediatric Brain Tumor Network Renewal

March 28, 2003

DeVita Considers Alternatives to Recommendation Of NCAB On Organ Systems Coordinating Center

June 1, 1984

Eppley Probe Could Lead to Tighter Reporting By NIH supported Investigators

June 17, 1977